ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030

The ASEAN point of care diagnostics market is expected to grow from USD 1.08 billion in 2025 to reach USD 1.36 billion in 2030, at a CAGR of 4.7% during the forecast period. Favorable government policies and funding investments drive the demand for Point of Care (POC) testing in the ASEAN region. Governments in these countries are increasingly supporting adopting such technologies to improve health access, reduce costs, and enhance patient outcomes. Through strategic partnerships, research initiatives, and nationwide screening campaigns, ASEAN governments promote using POC technologies to make healthcare accessible, lower costs, and improve patient outcomes. In several developing nations within the region, where health infrastructure is relatively underdeveloped, authorities encourage using POC devices to decentralize laboratory-based diagnostics and expand access to testing. These supportive initiatives are fostering the growth of POC diagnostics and creating new market opportunities for diagnostic firms in the ASEAN region.

“The infectious disease testing products segment is expected to register the highest growth rate in the ASEAN point of care diagnostics market, by product.”

Based on product, the ASEAN point of care diagnostics market is segmented into infectious disease testing products, glucose monitoring products, cardiometabolic testing products, coagulation monitoring products, pregnancy & fertility testing products, urinalysis testing products, cancer marker testing products, cholesterol testing products, hematology testing products, fecal occult testing products, drugs-of-abuse testing products, and other POC products. Among them, the infectious disease testing products segment is expected to grow at the highest CAGR, primarily driven by the region’s continuous efforts towards enhancing disease surveillance and outbreak control. Recurrent outbreaks of infectious diseases, in addition to the requirement for rapid diagnosis in both urban & rural healthcare facilities, are fueling the demand for effective POC solutions. Additionally, the rapid development of advanced molecular platforms and immunoassays will facilitate the effective and smooth identification of infectious diseases, further expanding adoption among ASEAN countries.

“By technology, the Biochemistry segment accounted for the largest market share in the ASEAN point of care diagnostics market in 2024.”

The ASEAN point of care diagnostics market is segmented by technology into lateral flow assays (immunoassays), rapid tests (molecular diagnostics), and biochemistry. In 2024, the Biochemistry segment accounted for the largest share of the market owing to its extensive usability in a variety of routine & essential diagnostic tests such as blood glucose checks, electrolyte analysis, liver function tests, and kidney function tests. The high prevalence of chronic & lifestyle-associated diseases like diabetes, cardiovascular disease, and kidney disorders in the ASEAN countries has also substantially necessitated the need for point-of-care testing solutions based on biochemistry. Moreover, the ease of operation, cost-effectiveness, and shorter turnaround time of biochemistry analyzers make them appropriate for decentralized healthcare environments such as community clinics, primary health centers, and emergency departments. The growing demand for early disease detection & diagnosis has further supported the implementation of biochemistry-based POC solutions in the ASEAN market.

“Vietnam is the fastest-growing market for point of care diagnostics in the ASEAN region”

The ASEAN market for point of care diagnostics is categorized into Vietnam, Laos, Cambodia, Malaysia, Myanmar, Philippines, Singapore, Thailand, Indonesia, and Brunei. Vietnam is expected to grow at the highest CAGR during the forecast period. Vietnam’s strong focus on strengthening its primary healthcare network and expanding nationwide screening programs—especially after the COVID-19 pandemic—has significantly increased the adoption of point-of-care diagnostic solutions in public and private healthcare facilities. Additionally, the country is committed to improving the early detection and management of infectious diseases, bolstered by its robust disease surveillance and monitoring systems, which will support long-term market growth. As reflected in its Joint External Evaluation and Global Health Security Index scores, Vietnam's impressive performance in global health security indicators highlights the healthcare system's growing capacity to implement point-of-care diagnostics in the coming years.

The break-up of the profile of primary participants in the ASEAN point of care diagnostics market:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30%
• By Designation: C-level - 27%, D-level - 18%, and Others - 55%

The key players in this market are Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan), Danaher Corporation (US), BD (US), QuidelOrtho Corporation (US), Cardinal Health (US), AccuBioTech Co., Ltd. (China), EKF Diagnostics Holdings plc (UK), bioMérieux (France), Thermo Fisher Scientific Inc. (US), BIOSYNEX SA (France), PTS Diagnostics (US), LifeScan IP Holdings, LLC (US), SD Biosensor, INC. (South Korea), CTK Biotech, Inc. (US), Wondfo (China), Trinity Biotech (Ireland), SEKISUI Diagnostics (US), Werfen (Spain), ARKRAY, Inc. (US), Xiamen Boson Biotech Co., Ltd. (China), Credo Diagnostics Biomedical Pte. Ltd. (Singapore), Anbio Biotechnology Inc. (Germany), and SG Diagnostics (Singapore).

Research Coverage:

This research report categorizes the ASEAN point of care diagnostics market by product (infectious disease testing products, glucose monitoring products, cardiometabolic testing products, coagulation monitoring products, pregnancy & fertility testing products, urinalysis testing products, cancer marker testing products, cholesterol testing products, hematology testing products, fecal occult testing products, drugs-of-abuse testing products, and other POC products), by technology [lateral flow assays (immunoassays), rapid tests (molecular diagnostics), and biochemistry], by end user (clinical laboratories, hospitals and critical care centers, outpatient settings and ambulatory care centers, home care settings, and other end users) and by country (Vietnam, Laos, Cambodia, Malaysia, Myanmar, Philippines, Singapore, Thailand, Indonesia, and Brunei). The report provides comprehensive information on the key factors influencing the growth of the ASEAN point-of-care diagnostics market, including drivers, restraints, opportunities, and challenges. It includes a detailed analysis of the major industry players, offering insights into their business overviews, solutions, key strategies, acquisitions, and agreements. Additionally, the report discusses new product and service launches and recent developments in the point-of-care diagnostics market. A competitive analysis of emerging startups within the ASEAN point-of-care diagnostics ecosystem is also included.

Reasons to buy this report:

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the ASEAN point of care diagnostics market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following points:

• Analysis of key drivers [Rising incidence of infectious diseases, increasing prevalence of chronic diseases, favorable government initiatives for POC testing, and the rising number of Public-Private Partnerships (PPPs)], opportunities (Gradual shift toward decentralized healthcare systems and availability of POC tests with multiplexing capabilities), restraints (Pricing pressure on manufacturers and stringent regulatory approval process for product commercialization), and challenges (Shortage of skilled healthcare providers and premium pricing of novel platforms) that influence the growth of the ASEAN point of care diagnostics market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ASEAN point of care diagnostics market.
• Market Development: Comprehensive information about lucrative markets—the report analyses the ASEAN point of care diagnostics market across various countries.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ASEAN point of care diagnostics market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan), and Danaher Corporation (US).

Tables List

Table 1 Asean Point Of Care Diagnostics Market: Key Data From Primary Sources

Table 2 Asean Point Of Care Diagnostics Market: Risk Assessment Analysis

Table 3 Hepatitis Disease Burden And Deaths Caused By Hepatitis, By Country (2022)

Table 4 Diabetes Estimates (Ages 20–79) And Diabetes-related Deaths,

By Country, 2021

Table 5 Projected Increase In Cancer Patients, By Country,

2022 Vs. 2035 Vs. 2045

Table 6 Indicative Selling Price Trend Of Poc Tests, By Product, 2023–2025

Table 7 Indicative Selling Price Trend Of Glucose Test Strips, By Key Player, 2023−2025

Table 8 Indicative Selling Price Trend Of Poc Pregnancy Test Kits, By Country, 2023–2025

Table 9 Asean Point Of Care Diagnostics Market: Role In Ecosystem

Table 10 Asean Point Of Care Diagnostics Market: Innovations & Patent Registrations, 2022–2024

Table 11 Import Data For Diagnostic & Laboratory Reagents (Hs Code 3822),

By Country, 2020–2024 (Usd Thousand)

Table 12 Export Data For Diagnostic & Laboratory Reagents (Hs Code 3822),

By Country, 2020–2024 (Usd Thousand)

Table 13 Asean Poc Diagnostics Market: Key Conferences & Events, 2025–2026

Table 14 Malaysia: Classification Of Ivd Medical Devices

Table 15 Myanmar: Classification Of Ivd Medical Devices

Table 16 Asean Countries: Key Regulatory Bodies, Government Agencies,

And Other Organizations

Table 17 Asean Point Of Care Diagnostics Market: Porter’s Five Forces Analysis

Table 18 Influence Of Stakeholders On Buying Process, By Technology (%)

Table 19 Key Buying Criteria, By Technology

Table 20 Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 21 Diabetes Prevalence (20–79 Yrs), Diabetes-related Deaths, And Proportion Of Undiagnosed Diabetes, By Country, 2021

Table 22 Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 23 Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Country, 2022–2030 (Usd Million)

Table 24 Glucometers: Currently Available Products, By Company

Table 25 Asean Point Of Care Diagnostics Market For Glucometers, By Country, 2022–2030 (Usd Million)

Table 26 Glucose Test Strips: Currently Available Products, By Company

Table 27 Asean Point Of Care Diagnostics Market For Glucose Test Strips,

By Country, 2022–2030 (Usd Million)

Table 28 Lancets & Lancing Devices: Currently Available Products, By Company

Table 29 Asean Point Of Care Diagnostics Market For Lancets, By Country,

2022–2030 (Usd Million)

Table 30 Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 31 Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Country, 2022–2030 (Usd Million)

Table 32 Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 33 Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Country, 2022–2030 (Usd Million)

Table 34 Tb Testing: Currently Available Products, By Company

Table 35 Asean Point Of Care Diagnostics Market For Tb Testing Products,

By Country, 2022–2030 (Usd Million)

Table 36 Influenza Testing: Currently Available Products, By Company

Table 37 Asean Point Of Care Diagnostics Market For Influenza Testing Products, By Country, 2022–2030 (Usd Million)

Table 38 Other Respiratory Infection Testing: Currently Available Products,

By Company

Table 39 Asean Point Of Care Diagnostics Market For Other Respiratory Infection Testing Products, By Country, 2022–2030 (Usd Million)

Table 40 Mosquito-borne Disease Testing: Currently Available Products,

By Company

Table 41 Asean Point Of Care Diagnostics Market For Mosquito-borne Disease Testing Products, By Country, 2022–2030 (Usd Million)

Table 42 Std Testing: Currently Available Products, By Company

Table 43 Asean Point Of Care Diagnostics Market For Std Testing Products,

By Country, 2022–2030 (Usd Million)

Table 44 Hiv Testing: Currently Available Products, By Company

Table 45 Asean Point Of Care Diagnostics Market For Hiv Testing Products,

By Country, 2022–2030 (Usd Million)

Table 46 Hai Testing: Currently Available Products, By Company

Table 47 Asean Point Of Care Diagnostics Market For Hai Testing Products,

By Country, 2022–2030 (Usd Million)

Table 48 Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 49 Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Country, 2022–2030 (Usd Million)

Table 50 Hepatitis B Testing: Currently Available Products, By Company

Table 51 Asean Point Of Care Diagnostics Market For Hepatitis B Testing Products, By Country, 2022–2030 (Usd Million)

Table 52 Hepatitis C Testing: Currently Available Products, By Company

Table 53 Asean Point Of Care Diagnostics Market For Hepatitis C Testing Products, By Country, 2022–2030 (Usd Million)

Table 54 Other Infectious Disease Testing: Currently Available Products,

By Company

Table 55 Asean Point Of Care Diagnostics Market For Other Infectious Disease Testing Products, By Country, 2022–2030 (Usd Million)

Table 56 Asean Point Of Care Diagnostics Market For Covid-19 Testing Products, By Country, 2022–2030 (Usd Million)

Table 57 Cardiometabolic Testing: Currently Available Products, By Company

Table 58 Asean Point Of Care Diagnostics Market For Cardiometabolic Testing Products, By Type, 2022–2030 (Usd Million)

Table 59 Asean Point Of Care Diagnostics Market For Cardiometabolic Testing Products, By Country, 2022–2030 (Usd Million)

Table 60 Asean Point Of Care Diagnostics Market For Cardiac Marker Testing Products, By Country, 2022–2030 (Usd Million)

Table 61 Asean Point Of Care Diagnostics Market For Hba1c Testing Products, By Country, 2022–2030 (Usd Million)

Table 62 Asean Point Of Care Diagnostics Market For Blood Gas & Electrolyte Testing Products, By Country, 2022–2030 (Usd Million)

Table 63 Coagulation Monitoring: Currently Available Products, By Company

Table 64 Asean Point Of Care Diagnostics Market For Coagulation Monitoring Products, By Country, 2022–2030 (Usd Million)

Table 65 Pregnancy & Fertility Testing: Currently Available Products,

By Company

Table 66 Asean Point Of Care Diagnostics Market For Pregnancy & Fertility Testing Products, By Country, 2022–2030 (Usd Million)

Table 67 Asean Point Of Care Diagnostics Market: Total Number Of Pregnancies, By Country, 2022−2030 (In Million)

Table 68 Hematology Testing: Currently Available Products, By Company

Table 69 Asean Point Of Care Diagnostics Market For Hematology Testing Products, By Country, 2022–2030 (Usd Million)

Table 70 Number Of Cases For Top Five Cancer Types, 2022

Table 71 Cancer Marker Testing: Currently Available Products, By Company

Table 72 Asean Point Of Care Diagnostics Market Of Cancer Marker Testing Products, By Country, 2022–2030 (Usd Million)

Table 73 Estimated Number Of New Cases Of Colorectal Cancer,

2022 Vs. 2035 Vs. 2045

Table 74 Fecal Occult Blood Testing: Currently Available Products, By Company

Table 75 Asean Point Of Care Diagnostics Market For Fecal Occult Blood Testing Products, By Country, 2022–2030 (Usd Million)

Table 76 Cholesterol Testing Products: Currently Available Products,

By Company

Table 77 Asean Point Of Care Diagnostics Market For Cholesterol Testing Products, By Country, 2022–2030 (Usd Million)

Table 78 Urinalysis Testing: Currently Available Products, By Company

Table 79 Asean Point Of Care Diagnostics Market For Urinalysis Testing Products, By Country, 2022–2030 (Usd Million)

Table 80 Drugs-of-abuse Testing: Currently Available Products, By Company

Table 81 Asean Point Of Care Diagnostics Market For Drugs-of-abuse Testing Products, By Country, 2022–2030 (Usd Million)

Table 82 Other Poc Products: Currently Available Products, By Company

Table 83 Asean Point Of Care Diagnostics Market For Other Poc Products,

By Country, 2022–2030 (Usd Million)

Table 84 Asean Point Of Care Diagnostics Market, By Technology,

2022–2030 (Usd Million)

Table 85 Biochemistry: Currently Available Products, By Company

Table 86 Asean Point Of Care Diagnostics Market For Biochemistry, By Country, 2022–2030 (Usd Million)

Table 87 Lateral Flow Assays: Currently Available Products, By Company

Table 88 Asean Point Of Care Diagnostics Market For Lateral Flow Assays (Immunoassays), By Country, 2022–2030 (Usd Million)

Table 89 Asean Point Of Care Diagnostics Market For Rapid Tests

(Molecular Diagnostics), By Country, 2022–2030 (Usd Million)

Table 90 Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 91 Asean Point Of Care Diagnostics Market For Home Care Settings,

By Country, 2022–2030 (Usd Million)

Table 92 Asean Point Of Care Diagnostics Market For Clinical Laboratories,

By Country, 2022–2030 (Usd Million)

Table 93 Asean Point Of Care Diagnostics Market For Hospitals And Critical Care Centers, By Country, 2022–2030 (Usd Million)

Table 94 Asean Point Of Care Diagnostics Market For Outpatient Settings And Ambulatory Care Centers, By Country, 2022–2030 (Usd Million)

Table 95 Asean Point Of Care Diagnostics Market For Other End Users,

By Country, 2022–2030 (Usd Million)

Table 96 Asean Point Of Care Diagnostics Market, By Country,

2022–2030 (Usd Million)

Table 97 Indonesia: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 98 Indonesia: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 99 Indonesia: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 100 Indonesia: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 101 Indonesia: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 102 Indonesia: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 103 Indonesia: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type,

2022–2030 (Usd Million)

Table 104 Indonesia: Asean Point Of Care Diagnostics Market, By Technology, 2022–2030 (Usd Million)

Table 105 Indonesia: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 106 Indonesia: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 107 Thailand: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 108 Thailand: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 109 Thailand: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 110 Thailand: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 111 Thailand: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 112 Thailand: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 113 Thailand: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 114 Thailand: Asean Point Of Care Diagnostics Market, By Technology, 2022–2030 (Usd Million)

Table 115 Thailand: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 116 Thailand: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 117 Malaysia: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 118 Malaysia: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 119 Malaysia: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 120 Malaysia: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 121 Malaysia: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 122 Malaysia: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 123 Malaysia: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 124 Malaysia: Asean Point Of Care Diagnostics Market, By Technology, 2022–2030 (Usd Million)

Table 125 Malaysia: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 126 Malaysia: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 127 Philippines: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 128 Philippines: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 129 Philippines: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 130 Philippines: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 131 Philippines: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 132 Philippines: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 133 Philippines: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type,

2022–2030 (Usd Million)

Table 134 Philippines: Asean Point Of Care Diagnostics Market, By Technology, 2022–2030 (Usd Million)

Table 135 Philippines: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 136 Philippines: Asean Point Of Care Diagnostics Market, By End User, 2022–2030 (Usd Million)

 

Table 137 Vietnam: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 138 Vietnam: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 139 Vietnam: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 140 Vietnam: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 141 Vietnam: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 142 Vietnam: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 143 Vietnam: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 144 Vietnam: Asean Point Of Care Diagnostics Market, By Technology,

2022–2030 (Usd Million)

Table 145 Vietnam: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 146 Vietnam: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 147 Singapore: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 148 Singapore: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 149 Singapore: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 150 Singapore: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 151 Singapore: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 152 Singapore: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 153 Singapore: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type,

2022–2030 (Usd Million)

Table 154 Singapore: Asean Point Of Care Diagnostics Market, By Technology, 2022–2030 (Usd Million)

Table 155 Singapore: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 156 Singapore: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 157 Myanmar: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 158 Myanmar: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 159 Myanmar: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 160 Myanmar: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

 

Table 161 Myanmar: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 162 Myanmar: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 163 Myanmar: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 164 Myanmar: Asean Point Of Care Diagnostics Market, By Technology, 2022–2030 (Usd Million)

Table 165 Myanmar: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 166 Myanmar: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 167 Cambodia: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 168 Cambodia: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 169 Cambodia: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 170 Cambodia: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 171 Cambodia: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 172 Cambodia: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 173 Cambodia: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type,

2022–2030 (Usd Million)

Table 174 Cambodia: Asean Point Of Care Diagnostics Market, By Technology, 2022–2030 (Usd Million)

Table 175 Cambodia: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 176 Cambodia: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 177 Laos: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 178 Laos: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 179 Laos: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 180 Laos: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 181 Laos: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 182 Laos: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 183 Laos: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type, 2022–2030 (Usd Million)

 

Table 184 Laos: Asean Point Of Care Diagnostics Market, By Technology,

2022–2030 (Usd Million)

Table 185 Laos: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 186 Laos: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 187 Brunei: Macroeconomic Indicators For Asean Point Of Care Diagnostics Market

Table 188 Brunei: Asean Point Of Care Diagnostics Market, By Product,

2022–2030 (Usd Million)

Table 189 Brunei: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Disease Type, 2022–2030 (Usd Million)

Table 190 Brunei: Asean Point Of Care Diagnostics Market For Respiratory Infection Testing Products, By Type, 2022–2030 (Usd Million)

Table 191 Brunei: Asean Point Of Care Diagnostics Market For Hepatitis Testing Products, By Type, 2022–2030 (Usd Million)

Table 192 Brunei: Asean Point Of Care Diagnostics Market For Glucose Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 193 Brunei: Asean Point Of Care Diagnostics Market For Cardiometabolic Monitoring Products, By Type, 2022–2030 (Usd Million)

Table 194 Brunei: Asean Point Of Care Diagnostics Market, By Technology,

2022–2030 (Usd Million)

Table 195 Brunei: Asean Point Of Care Diagnostics Market For Infectious Disease Testing Products, By Technology, 2022–2030 (Usd Million)

Table 196 Brunei: Asean Point Of Care Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 197 Overview Of Strategies Deployed By Key Companies In Asean Point Of Care Diagnostics Market, January 2021−march 2025

Table 198 Asean Point Of Care Diagnostics Market: Degree Of Competition

Table 199 Asean Point Of Care Diagnostics Market: Country Footprint

Table 200 Asean Point Of Care Diagnostics Market: Product Footprint

Table 201 Asean Point Of Care Diagnostics Market: Technology Footprint

Table 202 Asean Point Of Care Diagnostics Market: Detailed List Of Key Startups/Smes

Table 203 Asean Point Of Care Diagnostics Market: Competitive Benchmarking Of Key Startups/Smes, By Technology

Table 204 Asean Point Of Care Diagnostics Market: Competitive Benchmarking Of Key Startups/Smes, By Country

Table 205 Asean Point Of Care Diagnostics Market: Product Launches & Approvals, January 2021–march 2025

Table 206 Asean Point Of Care Diagnostics Market: Deals,

January 2021–march 2025

Table 207 Asean Point Of Care Diagnostics Market: Expansions,

January 2021–march 2025

Table 208 Abbott: Company Overview

Table 209 Abbott: Products Offered

Table 210 Abbott: Product Approvals, January 2021–march 2025

 

Table 211 Abbott: Deals, January 2021– March 2025

Table 212 F. Hoffmann-la Roche Ltd.: Company Overview

Table 213 F. Hoffmann-la Roche Ltd.: Products Offered

Table 214 F. Hoffmann-la Roche Ltd.: Product Launches & Approvals,

January 2021–march 2025

Table 215 F. Hoffmann-la Roche Ltd.: Deals, January 2021– March 2025

Table 216 Siemens Healthineers Ag: Company Overview

Table 217 Siemens Healthineers Ag: Products Offered

Table 218 Siemens Healthineers Ag: Product Approvals,

January 2021–march 2025

Table 219 Siemens Healthineers Ag: Deals, January 2021– March 2025

Table 220 Siemens Healthineers Ag: Expansions, January 2021– March 2025

Table 221 Sysmex Corporation: Company Overview

Table 222 Sysmex Corporation: Products Offered

Table 223 Sysmex Corporation: Expansions, January 2021−march 2025

Table 224 Danaher Corporation: Company Overview

Table 225 Danaher Corporation: Products Offered

Table 226 Bd: Company Overview

Table 227 Bd: Products Offered

Table 228 Bd: Deals, January 2021–march 2025

Table 229 Bd: Expansions, January 2021–march 2025

Table 230 Quidelortho Corporation: Company Overview

Table 231 Quidelortho Corporation: Products Offered

Table 232 Quidelortho Corporation: Product Approvals,

January 2021–march 2025

Table 233 Quidelortho Corporation: Deals, January 2021–march 2025

Table 234 Quidelortho Corporation: Expansions, January 2021–march 2025

Table 235 Cardinal Health: Company Overview

Table 236 Cardinal Health: Products Offered

Table 237 Cardinal Health: Deals, January 2021–march 2025

Table 238 Cardinal Health: Expansions, January 2021–march 2025

Table 239 Biomérieux: Company Overview

Table 240 Biomérieux: Products Offered

Table 241 Biomérieux: Product Approvals, January 2021–march 2025

Table 242 Biomérieux: Deals, January 2021–march 2025

Table 243 Ekf Diagnostics Holdings Plc: Company Overview

Table 244 Ekf Diagnostics Holdings Plc: Products Offered

Table 245 Ekf Diagnostics Holdings Plc: Product Launches,

January 2021–march 2025

Table 246 Ekf Diagnostics Holdings Plc: Deals, January 2021–march 2025

Table 247 Ekf Diagnostics Holdings Plc: Expansions, January 2021–march 2025

Table 248 Thermo Fisher Scientific Inc.: Company Overview

 

Table 249 Thermo Fisher Scientific Inc.: Products Offered

Table 250 Thermo Fisher Scientific Inc.: Product Launches,

January 2021–march 2025

Table 251 Thermo Fisher Scientific Inc.: Deals, January 2021–march 2025

Table 252 Accubiotech Co., Ltd.: Company Overview

Table 253 Accubiotech Co., Ltd.: Products Offered

Table 254 Accubiotech Co., Ltd.: Product Approvals, January 2021–march 2025

Table 255 Biosynex Sa: Company Overview

Table 256 Sd Biosensor, Inc.: Company Overview

Table 257 Sekisui Diagnostics: Company Overview

Table 258 Werfen: Company Overview

Table 259 Trinity Biotech: Company Overview

Table 260 Pts Diagnostics: Company Overview

Table 261 Lifescan Ip Holdings, Llc: Company Overview

Table 262 Ctk Biotech, Inc.: Company Overview

Table 263 Wondfo: Company Overview

Table 264 Arkray, Inc.: Company Overview

Table 265 Xiamen Boson Biotech Co., Ltd.: Company Overview

Table 266 Credo Diagnostics Biomedical Pte. Ltd.: Company Overview

Table 267 Anbio Biotechnology Inc.: Company Overview

Table 268 Sg Diagnostics: Company Overview

Figures List

Figure 1 Markets Covered & Regions Considered

Figure 2 Asean Point Of Care Diagnostics Market: Research Design

Figure 3 Asean Point Of Care Diagnostics Market: Key Industry Insights

Figure 4 Breakdown Of Primary Interviews: Supply- And Demand-side Participants

Figure 5 Breakdown Of Primary Interviews: By Company Type And Designation

Figure 6 Bottom-up Approach: Company Revenue Estimation Approach

Figure 7 Cagr Projections: Supply-side Analysis

Figure 8 Asean Point Of Care Diagnostics Market: Top-down Approach

Figure 9 Asean Point Of Care Diagnostics Market: Data Triangulation Methodology

Figure 10 Asean Point Of Care Diagnostics Market: Research Assumptions

Figure 11 Asean Point Of Care Diagnostics Market, By Product,

2025 Vs. 2030 (Usd Million)

Figure 12 Asean Point Of Care Diagnostics Market, By Technology,

2025 Vs. 2030 (Usd Million)

Figure 13 Asean Point Of Care Diagnostics Market, By End User,

2025 Vs. 2030 (Usd Million)

Figure 14 Asean Point Of Care Diagnostics Market, By Country,

2025 Vs. 2030 (Usd Million)

Figure 15 Rising Prevalence Of Infectious Diseases To Propel Market

Figure 16 Glucose Monitoring Products Segment To Dominate Market During Forecast Period

Figure 17 Biochemistry Segment To Hold Largest Market Share Till 2030

Figure 18 Home Care Settings And Clinical Laboratories To Account For Major Market Shares During Forecast Period

Figure 19 Vietnam To Register Highest Growth During Forecast Period

Figure 20 Asean Point Of Care Diagnostics Market: Drivers, Restraints, Opportunities, And Challenges

Figure 21 Estimates Of Tb Incidence For Southeast Asia Region,

By Age Group And Gender (2023)

Figure 22 Asean Point Of Care Diagnostics Market: Trends/Disruptions

Impacting Customers’ Businesses

Figure 23 Asean Point Of Care Diagnostics Market: Value Chain Analysis

Figure 24 Asean Point Of Care Diagnostics Market: Supply Chain Analysis

Figure 25 Asean Point Of Care Diagnostics Market: Ecosystem Analysis

Figure 26 Investment & Funding Scenario, 2021−2024

Figure 27 Asean Point Of Care Diagnostics Market: Patent Analysis,

January 2014–december 2024

Figure 28 Asean Point Of Care Diagnostics Market: Porter’s Five Forces Analysis

Figure 29 Influence Of Stakeholders On Buying Process, By Technology

Figure 30 Key Buying Criteria, By Technology

 

Figure 31 Asean Point Of Care Diagnostics Market: Potential Of Ai

Figure 32 Asean: Point Of Care Diagnostics Market Snapshot

Figure 33 Revenue Analysis Of Key Players In Asean Point Of Care

Diagnostics Market, 2022–2024

Figure 34 Market Share Analysis Of Key Players In Asean Point Of Care Diagnostics Market, 2024

Figure 35 Asean Point Of Care Diagnostics Market: Company Evaluation Matrix (Key Players), 2024

Figure 36 Asean Point Of Care Diagnostics Market: Company Footprint

Figure 37 Asean Point Of Care Diagnostics Market: Company Evaluation Matrix (Startups/Smes), 2024

Figure 38 Ev/Ebitda Of Key Vendors, 2025

Figure 39 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of Key Vendors, 2025

Figure 40 Asean Point Of Care Diagnostics Market: Brand/Product

Comparison Matrix

Figure 41 Abbott: Company Snapshot (2024)

Figure 42 F. Hoffmann-la Roche Ltd.: Company Snapshot (2024)

Figure 43 Siemens Healthineers Ag: Company Snapshot (2024)

Figure 44 Sysmex Corporation: Company Snapshot (2023)

Figure 45 Danaher Corporation: Company Snapshot (2024)

Figure 46 Bd: Company Snapshot (2024)

Figure 47 Quidelortho Corporation: Company Snapshot (2024)

Figure 48 Cardinal Health: Company Snapshot (2024)

Figure 49 Biomérieux: Company Snapshot (2024)

Figure 50 Ekf Diagnostics Holdings Plc: Company Snapshot (2023)

Figure 51 Thermo Fisher Scientific Inc.: Company Snapshot (2024)